ShareHope Medicine Co Ltd (8403) — Capital Reinvestment Ratio
Latest as of December 2025:
0.35x
ShareHope Medicine Co Ltd (8403) has a Capital Reinvestment Ratio of 0.35x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$113.37 Million) in capital expenditures (NT$39.14 Million). See ShareHope Medicine Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.35x
Capex / Operating Cash Flow
Operating Cash Flow
NT$113.37 Million
TWD
Capital Expenditures
NT$39.14 Million
TWD
Data as of
Dec 2025
Most recent filing
ShareHope Medicine Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks ShareHope Medicine Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for ShareHope Medicine Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see ShareHope Medicine Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | NT$364.12 Million | NT$131.81 Million | ▲ +3.8% |
| 2024 | 0.35x | NT$266.68 Million | NT$93.02 Million | ▼ -67.6% |
| 2023 | 1.08x | NT$257.13 Million | NT$277.20 Million | ▼ -46.1% |
| 2022 | 2.00x | NT$642.47 Million | NT$1.28 Billion | ▲ +372.7% |
| 2021 | 0.42x | NT$360.10 Million | NT$152.26 Million | ▼ -16.6% |
| 2020 | 0.51x | NT$717.74 Million | NT$364.00 Million | ▲ +144.7% |
| 2019 | 0.21x | NT$502.62 Million | NT$104.17 Million | ▼ -93.1% |
| 2018 | 3.02x | NT$33.91 Million | NT$102.27 Million | ▲ +6.4% |
| 2017 | 2.83x | NT$62.76 Million | NT$177.91 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow